105 related articles for article (PubMed ID: 29681575)
1. Sinus Standstill in a Patient after Intracoronary Papaverine Administration for a Coronary Fractional Flow Reserve.
Nauchi M; Sakai T; Yamawaki M; Ito Y
Int Heart J; 2018 May; 59(3):630-633. PubMed ID: 29681575
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the risk factors for ventricular arrhythmias secondary to QT prolongation induced by papaverine injection during coronary flow reserve studies using a 4 Fr angio-catheter.
Okabe Y; Otowa K; Mitamura Y; Murai H; Usui S; Kaneko S; Takamura M
Heart Vessels; 2018 Nov; 33(11):1358-1364. PubMed ID: 29713819
[TBL] [Abstract][Full Text] [Related]
3. Clinical Efficacy of Intracoronary Papaverine After Nicorandil Administration for Safe and Optimal Fractional Flow Reserve Measurement.
Inoue K; Sonoda S; Naka Y; Okabe H; Setoyama K; Miura T; Anai R; Araki M; Kataoka M
Int Heart J; 2021 Sep; 62(5):962-969. PubMed ID: 34544970
[TBL] [Abstract][Full Text] [Related]
4. Confirmation of maximal hyperemia by the incremental dose of intracoronary papaverine.
Nakayama M; Tanaka N; Yamashita J; Iwasaki K
Cardiovasc Interv Ther; 2020 Oct; 35(4):371-378. PubMed ID: 31939068
[TBL] [Abstract][Full Text] [Related]
5. Papaverine-induced polymorphic ventricular tachycardia during coronary flow reserve study of patients with moderate coronary artery disease.
Nakayama M; Tanaka N; Sakoda K; Hokama Y; Hoshino K; Kimura Y; Ogawa M; Yamashita J; Kobori Y; Uchiyama T; Aizawa Y; Yamashina A
Circ J; 2015; 79(3):530-6. PubMed ID: 25746536
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of combined administration of intracoronary papaverine plus intravenous adenosine 5'-triphosphate in assessment of fractional flow reserve.
Nishi T; Kitahara H; Iwata Y; Fujimoto Y; Nakayama T; Takahara M; Sugimoto K; Kobayashi Y
J Cardiol; 2016 Dec; 68(6):512-516. PubMed ID: 26811149
[TBL] [Abstract][Full Text] [Related]
7. Papaverine-induced QT interval prolongation and ventricular fibrillation in a patient with a history of drug-induced QT prolongation.
Goto M; Sato M; Kitazawa H; Takahashi M; Fuse K; Saito A; Okabe M; Aizawa Y
Intern Med; 2014; 53(15):1629-31. PubMed ID: 25088875
[TBL] [Abstract][Full Text] [Related]
8. Papaverine-induced polymorphic ventricular tachycardia in relation to QTU and giant T-U waves in four cases.
Nakayama M; Saito A; Kitazawa H; Takahashi M; Sato M; Fuse K; Okabe M; Hoshino K; Tanaka N; Yamashina A; Aizawa Y
Intern Med; 2012; 51(4):351-6. PubMed ID: 22333368
[TBL] [Abstract][Full Text] [Related]
9. Intracoronary papaverine induced myocardial lactate production in patients with angiographically normal coronary arteries.
Takeuchi M; Nohtomi Y; Kuroiwa A
Cathet Cardiovasc Diagn; 1996 Oct; 39(2):126-30. PubMed ID: 8922310
[TBL] [Abstract][Full Text] [Related]
10. ST elevation after intracoronary administration of Papaverine for fractional flow reserve estimation.
Jain RK; Chitnis NS; Hygriv Rao B
Indian Heart J; 2014; 66(3):289-93. PubMed ID: 24973833
[TBL] [Abstract][Full Text] [Related]
11. Comparison of intracoronary versus intravenous administration of adenosine for measurement of coronary fractional flow reserve.
Schlundt C; Bietau C; Klinghammer L; Wiedemann R; Rittger H; Ludwig J; Achenbach S
Circ Cardiovasc Interv; 2015 May; 8(5):. PubMed ID: 25908694
[TBL] [Abstract][Full Text] [Related]
12. Intracoronary and intravenous adenosine 5'-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans.
De Bruyne B; Pijls NH; Barbato E; Bartunek J; Bech JW; Wijns W; Heyndrickx GR
Circulation; 2003 Apr; 107(14):1877-83. PubMed ID: 12668522
[TBL] [Abstract][Full Text] [Related]
13. Duration of Hyperemia With Intracoronary Administration of Papaverine.
Mizukami T; Sonck J; Gallinoro E; Kodeboina M; Canvedra A; Nagumo S; Bartunek J; Wyffels E; Vanderheyden M; Shinke T; De Bruyne B; Collet C
J Am Heart Assoc; 2021 Feb; 10(3):e018562. PubMed ID: 33459027
[No Abstract] [Full Text] [Related]
14. Does pharmacologic coronary flow reserve reflect vasodilator responsiveness to increased myocardial demand in humans?
Rossen JD; Nahser PJ; Oskarsson H; Brown RE; Winniford MD
Coron Artery Dis; 1996 Jun; 7(6):479-84. PubMed ID: 8889365
[TBL] [Abstract][Full Text] [Related]
15. Comparison of standard- and high-dose intracoronary adenosine for the measurement of coronary fractional flow reserve (FFR).
Röther J; Achenbach S; Tröbs M; Blachutzik F; Nef H; Marwan M; Schlundt C
Clin Res Cardiol; 2016 Dec; 105(12):1003-1010. PubMed ID: 27307094
[TBL] [Abstract][Full Text] [Related]
16. Polymorphous ventricular tachycardia after intracoronary papaverine: a report of 3 cases.
Zhang X; Shen W; Cai X; Zheng A
Chin Med Sci J; 1993 Dec; 8(4):248-9. PubMed ID: 8032075
[TBL] [Abstract][Full Text] [Related]
17. Comparison of intravenous adenosine to intracoronary papaverine for calculation of pressure-derived fractional flow reserve.
van der Voort PH; van Hagen E; Hendrix G; van Gelder B; Bech JW; Pijls NH
Cathet Cardiovasc Diagn; 1996 Oct; 39(2):120-5. PubMed ID: 8922309
[TBL] [Abstract][Full Text] [Related]
18. Catecholaminergic polymorphic ventricular tachycardia with associated sinus node dysfunction.
Joshi P; Saxena A; Kaul U; Mansoor AH
Indian Heart J; 2010; 62(1):84-6. PubMed ID: 21180045
[TBL] [Abstract][Full Text] [Related]
19. [Measurement of coronary flow reserve using adenosine 5'-triphosphate in dogs].
Kohno H; Yamada H; Azuma A; Kondo M; Yagi T; Kawata K; Tatsukawa H; Sugihara H; Nakagawa M
J Cardiol; 1998 Jul; 32(1):1-8. PubMed ID: 9739511
[TBL] [Abstract][Full Text] [Related]
20. Right versus left atrial pacing in patients with sick sinus syndrome and paroxysmal atrial fibrillation (Riverleft study): study protocol for randomized controlled trial.
Ramdjan TT; van der Does LJ; Knops P; Res JC; de Groot NM
Trials; 2014 Nov; 15():445. PubMed ID: 25403703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
